New possibilities in pharmacotherapy for the heart failure with reduced ejection fraction treatment in patients with recent deterioration
Heart failure with reduced ejection fraction (HFrEF) is a public health issue, because some patients, despite using standard treatment, still develop worsening heart failure. The risk of adverse outcomes is especially high in patients who require readmission or emergency care on an outpatient basis....
Saved in:
Main Author: | I. V. Gribkova (Author) |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New to paradigm for the treatment of heart failure with reduced ejection fraction?
by: Delfín Rodríguez Leyva
Published: (2015) -
Role of ARNI upgraded in treatment of heart failure with reduced ejection fraction
by: Swetha Amaresh Biradar
Published: (2021) -
ALGORITHM FOR THE TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTION
by: E. V. Reznik, et al.
Published: (2018) -
COMPARATIVE ANALYSIS OF HOSPITAL PHARMACOTHERAPY OF CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTIONS IN 2009-2010 AND 2014-2015
by: O. V. Reshetko, et al.
Published: (2018) -
Outcome of angiotensin receptor-neprilysin inhibitor on anxiety and depression in heart failure with reduced ejection fraction vs. heart failure with preserved ejection fraction
by: Jahanzeb Malik, et al.
Published: (2021)